Results 31 to 40 of about 1,512,475 (325)

Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.

open access: yesMMWR. Morbidity and mortality weekly report, 2022
On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months-5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 weeks ...
MD Katherine E. Fleming-Dutra   +20 more
semanticscholar   +1 more source

Development of High-Grade Sarcoma After Second Dose of Moderna Vaccine

open access: yesCureus, 2023
Coronavirus disease 2019 (COVID-19) is a disease characterized by predominantly respiratory symptoms, which can progress to respiratory failure. Due to the novelty of the vaccines, it is difficult to assess if there are any associated long-term side ...
Edward Bae   +5 more
semanticscholar   +1 more source

Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.

open access: yesJAMA dermatology, 2021
Importance In response to the coronavirus disease 2019 (COVID-19) pandemic, 2 mRNA vaccines (Pfizer-BioNTech and Moderna) received emergency use authorization from the US Food and Drug Administration in December 2020.
Margaret S. Johnston   +3 more
semanticscholar   +1 more source

Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines

open access: yesPostgraduate medical journal, 2021
Introduction A worldwide vaccination campaign is underway to bring an end to the SARS-CoV-2 pandemic; however, its success relies heavily on the actual willingness of individuals to get vaccinated. Social media platforms such as Twitter may prove to be a
R. Marčec, R. Likić
semanticscholar   +1 more source

Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records

open access: yesVaccines, 2023
Prior research generally finds that the Pfizer-BioNTech (BNT162b2) and Moderna (mRNA1273) COVID-19 vaccines provide similar protection against mortality, sometimes with a Moderna advantage due to slower waning.
V. Atanasov   +9 more
semanticscholar   +1 more source

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults

open access: yesHuman Vaccines & Immunotherapeutics, 2023
This interim analysis of an ongoing phase 1 randomized clinical trial evaluated the safety, reactogenicity, and immunogenicity of mRNA-1283, a next-generation SARS-CoV-2 messenger RNA (mRNA)-based vaccine encoding two segments of the spike protein (i.e ...
Patrick Yassini   +6 more
doaj   +1 more source

Cultural industries, nation and staten in the work of Renato Ortiz: a view from inside the Anglosphere [PDF]

open access: yes, 2018
This short essay reflects on Renato Ortiz’s work and its reception in the Anglosphere. It then discusses the author’s meeting with Ortiz in Scotland during a European-Latin American ‘encounter’ set up to discuss cultural identity and communication ...
Schlesinger, Philip
core   +2 more sources

Reinventando la enseñanza de la Historia Moderna en Secundaria: la utilización de ChatGPT para potenciar el aprendizaje y la innovación docente

open access: yesStudia Historica: Historia Moderna, 2023
Este artículo tiene como objetivos principales utilizar ChatGPT para crear contenidos teóricos, ejercicios y actividades prácticas en el ámbito de la enseñanza de la Historia Moderna en la educación secundaria, y valorar la calidad de sus aportaciones ...
Antonio Carrasco Rodríguez
semanticscholar   +1 more source

Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system

open access: yesEClinicalMedicine, 2022
Summary Background mRNA COVID-19 vaccines manufactured by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) have been shown to be efficacious but have not been compared in head-to-head clinical trials.
G. Ioannou, E. Locke, P. Green, K. Berry
semanticscholar   +1 more source

Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia

open access: yesNature Communications, 2020
Propionic acidemia is a serious pediatric inherited disorder with no effective treatments. Here the authors demonstrate that delivering dual mRNAs as an enzyme replacement approach can be used as an effective therapy in a mouse model of propionic ...
Lei Jiang   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy